Cash Need and Valuation: two key elements for a successful Investment Round
...
...
...
...
FoodTech is a key pillar in GENESIS Biomed strateg...
Dr. Scott Boyer joins Chemotargets as new CEO....
Aortyx is the 1st winner of the Àlex Casta Awards...
Aortyx is the 1st winner of the Àlex Casta Awards...
Aortyx's pre-clinical studies have been successful...
ADmit Therapeutics consigue el apoyo de grandes or...
Madrid region is living a great moment of entrepre...
Interview with Joan Roca, chef at El Celler de Can...
Life sciences investors are optimistic about the f...
Six entrepreneurs share their first-hand experienc...
Having a solid scientific project and the right pa...
ITEMAS has designed a form to evaluate the maturit...
El doctor Juan Domingo Gispert y su equipo trabaja...
Which are the needs of innovation projects born in...
Agnès Arbat and Ignasi Canals are the cofounders ...
Ignasi Canals and Agnès Arbat are the entrepreneu...
Droplite has been joined already by Genesis Ventur...
GENESIS Biomed, consultoría especializada en star...
GENESIS Biomed, consultoría especializada en star...
The Spanish biotech ecosystem comprises large univ...
GENESIS Biomed is proud to announce the creation o...
GENESIS Biomed was founded today. Its founder a...
million euros raised
in 7 years
GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers.
Based in our expertise we help entrepreneurs and researchers to shape their business plan and we support them in the private fundraising process. We have raised 80 M€ in the last years in 21 rounds.
We are Associate Partner at EIT Health and we are engaged to 23 EU projects with TOP EU institutions: H2020, Horizon Europe, EIT Health and EIT Digital.
Our expertise domains are biopharmaceutical, biotechnological, medical devices, in vitro diagnostic, digital health, artificial intelligence, nutraceutical and cosmetic. With more than 20 years of expertise in the healthcare sector, we are born in May 2017 and we are headquartered in the Barcelona Science Park, and also with company sites in Madrid center and at La Marina in Valencia.
From our foundation in May 2017
Startups, Hospitals, Academia, Investors, Big companies
From Business Plan to Strategic Plan
With Venture Capital, Family Offices and Business Angels
Private and also public fundraising
Horizon Europe, EIT Health, EIT Digital and H2020
Global Data, Pitchbook, SABI, Merger&Market, Disqover
Directors, Senior Consultants and Consultants
50% each
Without capital increase or debt
Foreseen closing 2024 at 2 M€
Barcelona Science Park, Madrid Down-Town and Marina de Valencia
Close to our clients in the main biomedical clusters
ACCIO, EIT Health, ITEMAS, ASEBIO, CataloniaBio&HT, Bioval, CSMC, DIH·bio, CITT
GENESIS Ventures and GENESIS Tech Transfer Boost
With both vehicles
With a potential of 25 projects in total
The company also manages GENESIS Ventures and GENESIS Tech Transfer Boost two investment vehicles with a total size of 3,5 M€ that invest in early-stage biomedical research projects to accelerate their development and reach key value milestones with the foundation of a company and the attraction of a first round of investment from other venture funds.
EIT Health leverages the expertise of more than 140 leading organisations spanning key areas of healthcare, such as pharma, medtech, payers, research institutions and universities.
ITEMAS is an innovation platform for medical and healthcare technologies to facilitate knowledge transfer to the productive sector.
ASEBIO brings together companies, associations, foundations, universities, research and technology centres that carry out activities directly or indirectly related to biotechnology in Spain.
CataloniaBio & HealthTech is the association of companies in the biomedicine and health arena in Catalonia.
The Mental Health Cluster is a non-profit organization that works to build an ecosystem that energizes the mental health, neuroscience and aging sectors.
DIH bio is a powerful non-profit public-private consortium led and coordinated by the UAM with the mission of promoting the health and biomedical sector through the development and implementation of digital technologies.
The Cluster of Technological Innovation and Talent (CITT), in biomedical technologies and biotechnology in the Madrid region, is an entity that promotes research and innovation in this area in a transversal and multisectoral way, promoting collaboration and knowledge transfer between public and private agents.
BIOVAL is the Association of Companies and Entities in the BIO sector that encompasses Biotechnology, Biomedicine and Bioeconomy, and which constitute the cluster of the Valencian Community. Its objective is to turn this community into a national and international leader in research and business development in this sector.
GENESIS Biomed and especially its CEO and founder, Josep Lluís Falcó, have supported Anaconda Biomed since the before the start-up was founded. The advice received from GENESIS has been very valuable in helping our company achieve its goals. This collaboration is still on going and we are very pleased with everything they have contributed to our project.
Ofir Arad
CEO Anaconda Biomed - http://anaconda.bio/
Weekly contact, hard-work, proximity, fast response and professionalism define our relationship with GENESIS. They are one more member of our team, creating a real, structured pathway. Together, we raised an initial investment, thanks to their friendly, personalised advice.
Adrià Maceira
CEO CreatSens Health - http://creatsens.com/
MJN Neuroserveis has developed a medical device to record and assess the risk of an epileptic crisis. The project began as the personal venture of one of the co-founders, as he has a daughter affected by this disease. Thanks to the help of GENESIS Biomed, at MJN we have been able to understand the clinical, regulatory, financing, commercial planning and other steps that need to be taken so we can undertake a project of this kind, not merely at the planning level. GENESIS Biomed is currently helping us to execute all these plans to make the MJN project happen.
Salvador Gutiérrez
CEO MJN Neuroserveis - http://mjn.cat/
I just wanted to share a few lines on the great job you are doing. As far as we've seen, all the companies you work with are boosted by the advice you give them. Specifically, GENESIS is providing us with due diligence advice on the biotechnology sector, which helps us in searching companies to invest in. Thanks for your help.
Marc Botet
CEO Jormavi S.L.
We have begun a fruitful relationship with GENESIS Biomed. As a TTO we can leverage GENESIS wide expertise in developing life science projects. From a regulatory affairs point of view, GENESIS provides us a vantage point to prioritise our next steps by designing an optimised roadmap for the development of the project together. In terms of investment, GENESIS Ventures has contributed to moving a project forward in the value chain, so we can cross with the Valley of Death with fewer uncertainties.
Lucas Martín
Technology Transfer Manager UAB - http://www.uab.cat/
The collaboration with GENESIS Biomed started last year and it was profitable for both organisations. GENESIS has helped us to draw up the EIT Health Spain strategic plan 2017-2020 and EIT Health has the doors of an international network of excellence to the company. This collaboration is a good example of how to integrate local ecosystem key players and strong partners who are leaders in European innovation.
Marco Pugliese
CEO EIT Health Spain - https://www.eithealth.eu/
It is always a great pleasure to work with GENESIS! The professionalism and dedication of the members of this company is reflected in great success when evaluating the results of their work. Our current joint project: HOOP, a wearable ambulatory service for Parkinson's patients, has been chosen to begin a new business venture as part of ACTUA UPM thanks to its support. I wish GENESIS and its members great success!
María Teresa Arredondo
Director of LifeSTech. Director of Vodafone Chair at UPM - http://www.upm.es/
We consider ourselves fortunate to be able to draw on the advice and facilities of GENESIS Biomed in our everyday work. Its experience, networking, cordiality and, above all, honesty and commitment to our company, have made it possible for the CORNEA Project to move forward more solidly, safely and effectively. As CEO of CORNEA, I cannot contemplate moving forward without the inestimable help of GENESIS Biomed.
Pere del Campo
CEO CORNEA Project - http://www.corneaproject.com/
We have been working with GENESIS Biomed from the very beginning and Josep Lluís Falcó was a key collaborator in raising our first funding round. Far from being just a consulting company, GENESIS Biomed’s involvement in our project has made them a member of GlyCardial’s team.
Judit Cubedo
CEO GlyCardial Diagnostics - http://www.glycardial.com/
GENESIS Biomed was a key figure in the foundation of Leukos Biotech, but, more importantly, they have supported and advised us as we have grown and evolved, adapting their services to our changing needs. After two years working together, GENESIS Biomed has become an indispensable source of assistance, guidance and encouragement.
Erique Llaudet
CEO Leukos Biotech - http://www.leukosbiotech.com/
Josep Lluís has been working with us since the very beginning of AptaTargets. The aim was for him to help us with an initial roadmap for the company development, from the early preclinical stage (where we then were) to clinical stages and the market. Mutually positive- feelings convinced us to continue working with Josep Lluís in one of the critical steps for a start-up, which is closing an investment round. This was a very challenging step, as AptaTargets was based on an almost unknown technology (aptamers) and a scary first indication (stroke). Josep Lluís played an important role, supporting us in different technical disciplines, such as regulations and CMC (chemicals, manufacturing & controls), as well as in business-related activities. He had been through this process before many times and his experience was valuable. We also enjoyed his human support in helping us to overcome difficulties, and this is also very valuable!.
David Segarra
CEO AptaTargets - http://www.aptatargets.com/
As Executive Director of Peptomyc, I would like to thank Genesis Biomed and its founder and director Dr Josep Lluís Falcó for their continuous professional support over the last few years. The Genesis team includes highly qualified health professionals who have been working with us since the very beginning of Peptomyc in the business world. His enthusiasm for our project has been continuous and very helpful. Genesis’s consultancy has supported us in preparing a business plan, strategic consulting, a market study and the preparation of a regulatory development plan, as well as the search for public and private funds. Our particular gratitude goes to Dr Falcó, for having worked hard, suffered and celebrated with us at every step of our project as an integral part of our team.
Laura Soucek
CEO Peptomyc - http://www.peptomyc.com/